National Law Journal - China has stepped up IP Enforcement Recently
By Scott M. Flicker and Matthew S. Dunne
IN JULY 2004, China’s State Intellectual Property Office (SIPO) invalidated the patent on Viagra that it had granted to Pfizer Inc. just three years earlier. Numerous observers quickly seized on this decision as yet one more sign of the dire state of intellectual property rights in China. But instead of heralding the death (or dearth) of IP rights in China, the Viagra case could be viewed as highlighting the birth of a new era for IP rights enforcement in China.